Investment and Collaboration Agreement by and between BioLineRx Ltd. and Novartis Pharma AG December 16, 2014Investment and Collaboration Agreement • March 23rd, 2015 • BioLineRx Ltd. • Pharmaceutical preparations • New York
This Investment and Collaboration Agreement (the “Agreement”) is entered into as of December 16, 2014 (the “Effective Date”) by and between Novartis Pharma AG, a corporation organized and existing under the laws of Switzerland and having its principal place of business at Lichtstrasse 35, CH-4056, Basel, Switzerland (“NVS”), and BioLineRx Ltd., a company organized and existing under the laws of the State of Israel and having a principal place of business at 19 Hartum Street, Jerusalem, 91450, Israel (“BioLine”).
